An Oncology biotech pioneering RAD51 inhibition and other DDR mechanisms
Sukanya has over 20 years of research experience, including over 14 years in industry. At Satya, Sukanya leads the science, guiding programs from target selection to candidate nomination
Ph.D., University of California San Diego (UCSD) and San Diego State University (SDSU); M.Pharm., Jadavpur University, India
She has participated and led multiple programs particularly focused in oncology and immune-oncology, starting from critical target evaluation, strategic differentiation, assay development, design of appropriate screening cascades, candidate identification and profiling, across many programs.
She has been formerly Principal Scientist at Lupin, and closely involved in programs that have since reached clinical development. Along with a brilliant academic career, Sukanya has been the recipient of various awards for her outstanding contributions as a scientist through her career
Brahma received his Ph.D. in Medicinal Chemistry from NIPER (Mohali) in 2011. Thereafter, he worked with Integral Biosciences for over 12 years, where he drove multiple candidates to clinic, some of which went on to gain FDA approval with collaborators including Medivation and Nuvation. He has published more than 10 papers in peer reviewed journals and is a co-inventor in over 50 patents. His extensive experience includes discovery and pre-clinical development of multiple candidates in oncology, metabolic diseases and CNS.
Brahma received his Ph.D. in Medicinal Chemistry from NIPER (Mohali) in 2011. Thereafter, he worked with Integral Biosciences for over 12 years, where he drove multiple candidates to clinic, some of which went on to gain FDA approval with collaborators including Medivation and Nuvation.
He has published more than 10 papers in peer reviewed journals and is a co-inventor in over 50 patents. His extensive experience includes discovery and pre-clinical development of multiple candidates in oncology, metabolic diseases and CNS.
Sukanya has over 20 years of research experience, including over 14 years in industry. At Satya, Sukanya leads the science, guiding programs from target selection to candidate nomination
Ph.D., University of California San Diego (UCSD) and San Diego State University (SDSU); M.Pharm., Jadavpur University, India
She has participated and led multiple programs particularly focused in oncology and immune-oncology, starting from critical target evaluation, strategic differentiation, assay development, design of appropriate screening cascades, candidate identification and profiling, across many programs.
She has been formerly Principal Scientist at Lupin, and closely involved in programs that have since reached clinical development. Along with a brilliant academic career, Sukanya has been the recipient of various awards for her outstanding contributions as a scientist through her career
